Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NBIX
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Neurocrine Biosciences Inc (NBIX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

NBIX trades at $155.64, down 1.71% on the day, with a bullish technical outlook from moving averages but a neutral signal from oscillators. The company reported strong fundamentals with a 97.91% gross margin and 20.91% net income margin, and Q1 2026 earnings beat expectations. Recent news highlights investor conference participation and positive traction for Crenessity, though Vykat XR faces safety scrutiny.
The investment case is supported by robust profitability, analyst consensus favoring a buy with a $207.07 price target, and institutional accumulation. Key risks include drug safety concerns, execution challenges in a competitive landscape, and a premium valuation that demands sustained growth to justify further upside.
Read full analysis

Key Stats

  • Market Cap
    $15.82B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    -
  • Enterprise Value
    $15.83B
  • Div Yield
    -
  • Trading Activity
    -
$155.64
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Most Recent News

Content is generated by Aura AI

Johnson & Johnson leads 2026 defensive stocks with 35% gain, outpacing Coca-Cola and Procter & Gamble.

In 2026, among defensive stocks, Johnson & Johnson outperformed with a 35% gain driven by strong oncology and immunology sales and a robust pipeline. Coca-Cola followed with a 28% rise, benefiting from steady global volume and pricing power, while Pr...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Johnson & Johnson leads 2026 defensive stocks with 35% gain, outpacing Coca-Cola and Procter & Gamble.

Investors withdrew $700M from software ETF IGV before Snowflake's strong earnings report boosted the sector.

Investors pulled $700 million from the iShares Expanded Tech-Software Sector ETF (IGV) just hours before Snowflake reported a strong quarter with 37% product revenue growth and an increased full-year forecast, driven partly by AI. Despite Snowflake's...

Market News
4 hours ago
24/7 Wall Street
Neutral
Investors withdrew $700M from software ETF IGV before Snowflake's strong earnings report boosted the sector.

Applied Optoelectronics leads 2026 optics stocks with 203% gain amid AI datacenter boom.

In 2026, AI datacenter spending has driven strong gains in U.S. optics stocks, with Applied Optoelectronics leading at a 203% year-to-date increase. Lumentum and Coherent also posted gains of 139% and 53%, respectively, outperforming the broader semi...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Applied Optoelectronics leads 2026 optics stocks with 203% gain amid AI datacenter boom.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $15.82B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    -
  • Enterprise Value
    $15.83B
  • Div Yield
    -
  • Trading Activity
    -
$155.64
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!